MedPath

Neurotune AG

Neurotune AG logo
🇨🇭Switzerland
Ownership
Holding
Established
2005-01-01
Employees
1
Market Cap
-
Website
http://www.neurotune.com

Dimiracetam in Painful Neuropathies Affecting AIDS Patients

Phase 2
Conditions
Acquired Immunodeficiency Syndrome
Interventions
First Posted Date
2011-10-03
Last Posted Date
2011-10-03
Lead Sponsor
Neurotune AG
Target Recruit Count
244
Registration Number
NCT01444690
Locations
🇨🇭

Neurotune AG, Lugano, Switzerland

Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy

Phase 2
Completed
Conditions
Neuropathy
AIDS
Interventions
Drug: sugar pill
First Posted Date
2010-06-02
Last Posted Date
2010-06-02
Lead Sponsor
Neurotune AG
Target Recruit Count
116
Registration Number
NCT01135251
Locations
🇿🇦

Aurora Hospital Triple Research, Port Elizabeth, South Africa

© Copyright 2025. All Rights Reserved by MedPath